Your browser doesn't support javascript.
loading
Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depression.
Farmer, Cristan A; Gilbert, Jessica R; Moaddel, Ruin; George, Jomy; Adeojo, Lilian; Lovett, Jacqueline; Nugent, Allison C; Kadriu, Bashkim; Yuan, Peixiong; Gould, Todd D; Park, Lawrence T; Zarate, Carlos A.
Affiliation
  • Farmer CA; Section on the Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.
  • Gilbert JR; Section on the Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.
  • Moaddel R; National Institute on Aging, National Institutes of Health, Baltimore, MD, USA.
  • George J; Clinical Pharmacokinetics Research Unit, Pharmacy Department, National Institutes of Health, Bethesda, MD, USA.
  • Adeojo L; Clinical Pharmacokinetics Research Unit, Pharmacy Department, National Institutes of Health, Bethesda, MD, USA.
  • Lovett J; National Institute on Aging, National Institutes of Health, Baltimore, MD, USA.
  • Nugent AC; Section on the Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.
  • Kadriu B; Magnetoencephalography Core Facility, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.
  • Yuan P; Section on the Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.
  • Gould TD; Section on the Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.
  • Park LT; Departments of Psychiatry, Pharmacology, and Anatomy and Neurobiology, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Zarate CA; Veterans Affairs Maryland Health Care System, Baltimore, MD, USA.
Neuropsychopharmacology ; 45(8): 1398-1404, 2020 07.
Article in En | MEDLINE | ID: mdl-32252062
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Depressive Disorder, Major / Ketamine Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: Neuropsychopharmacology Journal subject: NEUROLOGIA / PSICOFARMACOLOGIA Year: 2020 Type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Depressive Disorder, Major / Ketamine Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: Neuropsychopharmacology Journal subject: NEUROLOGIA / PSICOFARMACOLOGIA Year: 2020 Type: Article Affiliation country: United States